Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients

Review of ten studies (603 randomised participants) found the efficacy and safety of glucose‐lowering agents in the treatment of pre‐existing and new‐onset diabetes in kidney transplant recipients is questionable. Appropriately blinded, larger, and higher quality RCTs are needed.

Source:

Cochrane Database of Systematic Reviews